Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 1:11 AM
Ignite Modification Date: 2025-12-25 @ 11:22 PM
NCT ID: NCT02734693
Description: None
Frequency Threshold: 5
Time Frame: 3 weeks
Study: NCT02734693
Study Brief: A Study to Evaluate the Efficacy and Safety of Dasotraline in Children 6 to 12 Years of Age With Attention-Deficit Hyperactivity Disorder (ADHD) in a Simulated Classroom Setting.
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Placebo Placebo capsule 0 None 1 56 14 56 View
Dasotraline 6mg Dasotraline capsule 6mg/day 0 None 0 20 14 20 View
Dasotraline 4mg Dasotraline capsule 4mg/day 0 None 0 56 24 56 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Hand fracture SYSTEMATIC_ASSESSMENT Injury, poisoning and procedural complications MedDRA 19.0 View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Postural orthostatic tachycardia syndrome SYSTEMATIC_ASSESSMENT Cardiac disorders MedDRA 19.0 View
Abdominal pain upper SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 19.0 View
Dry mouth SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 19.0 View
Vomiting SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 19.0 View
Fatigue SYSTEMATIC_ASSESSMENT General disorders MedDRA 19.0 View
Oral herpes SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 19.0 View
Contusion SYSTEMATIC_ASSESSMENT Injury, poisoning and procedural complications MedDRA 19.0 View
Weight decreased SYSTEMATIC_ASSESSMENT Investigations MedDRA 19.0 View
Decreased appetite SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders MedDRA 19.0 View
Musle spasms SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders MedDRA 19.0 View
Dizziness postural SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA 19.0 View
Headache SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA 19.0 View
Affect lability SYSTEMATIC_ASSESSMENT Psychiatric disorders MedDRA 19.0 View
Delusion SYSTEMATIC_ASSESSMENT Psychiatric disorders MedDRA 19.0 View
Emotional poverty SYSTEMATIC_ASSESSMENT Psychiatric disorders MedDRA 19.0 View
Hallucination tactile SYSTEMATIC_ASSESSMENT Psychiatric disorders MedDRA 19.0 View
Hallucination visual SYSTEMATIC_ASSESSMENT Psychiatric disorders MedDRA 19.0 View
Initial insomnia SYSTEMATIC_ASSESSMENT Psychiatric disorders MedDRA 19.0 View
Insomnia SYSTEMATIC_ASSESSMENT Psychiatric disorders MedDRA 19.0 View
Irritability SYSTEMATIC_ASSESSMENT Psychiatric disorders MedDRA 19.0 View
Nightmare SYSTEMATIC_ASSESSMENT Psychiatric disorders MedDRA 19.0 View
Tic SYSTEMATIC_ASSESSMENT Psychiatric disorders MedDRA 19.0 View